Largest European market opening creating cross-border opportunities
BULLISH
Four New Markets Open in 2026
Expanding addressable market for international operators
REGULATORY
UN Treaty Modernization Discussions Advancing
International framework evolving to accommodate legal markets
MACRO
Cross-Border Capital Flows Accelerating
International investors increasing allocation to cannabis sector
Data loading…
219MGlobal Cannabis Users
4.3%Global Prevalence (15–64)
5,600tAnnual Seizures
Source: UNODC World Drug Report 2024
Regional Prevalence
Cannabis-Legal Countries: Economic Indicators
Country
GDP/Cap (USD)
Population
Health Exp. (% GDP)
Unemployment (%)
Trade (% GDP)
Loading World Bank data…
Complimentary Research
Would you like an international market report?
Request a complimentary, fully customized analysis of regulatory timelines, market sizing, and cross-border investment opportunities — tailored to the regions and markets you’re evaluating.
Disclaimer: Cannabis Investor News is for informational purposes only—not investment advice. We are not registered with the SEC, FINRA, or any regulatory body. Data may be delayed or inaccurate. Cannabis securities carry significant risk; you could lose your entire investment. Always consult a licensed financial advisor and verify all information independently before making any investment decision.
Global Cannabis Data — International Markets and Policy Tracker
Track international cannabis market developments, regulatory frameworks, and cross-border data with CIN's Global Cannabis dashboard. The global cannabis industry extends far beyond North America, with active medical and recreational markets in Germany, Australia, Israel, Thailand, Colombia, and other jurisdictions advancing cannabis legalization and commercialization.
CIN's global coverage monitors key international cannabis markets including Canada's mature recreational market (the world's largest legal cannabis market by revenue), Germany's emerging adult-use framework, and Australia's expanding medical cannabis program. Export data tracks Canadian cannabis shipment volumes, which have doubled annually as international demand grows and domestic oversupply drives producers to seek foreign markets. International cannabis policy developments directly impact publicly traded cannabis companies with global operations. Companies like Tilray Brands, Organigram, and Aurora Cannabis derive significant revenue from international medical cannabis markets. Policy changes in major markets — such as Germany's 2024 adult-use legalization or the United Kingdom's evolving medical cannabis framework — create investment catalysts that CIN tracks and analyzes.
The global dashboard also covers international cannabis regulatory bodies, trade agreements affecting cannabis commerce, and emerging market opportunities in Latin America, Southeast Asia, and Africa where cannabis legalization is progressing. Understanding global cannabis dynamics provides essential context for evaluating companies with international operations and export strategies.